Curcumin Unknown Status Phase 3 Trials for Colon Neoplasms Treatment

IndicationsStatusPurposePhase
Unknown StatusTreatment3
clinicaltrials.gov IdentifierTitleDrugs
NCT00295035Phase III Trial of Gemcitabine, Curcumin and Celebrex in Patients With Metastatic Colon Cancer